Acute and chronic effects of medicinal cannabis use on anxiety and depression in a prospective cohort of patients new to cannabis
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2025.119829 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von David Wolinsky und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA. Hauptthemen laut MEDLINE: Medical Marijuana, Anxiety, Anxiety Disorders, Depression. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse, Thomas Jefferson University.
Themen: Depression
Abstract (Originalsprache)
INTRODUCTION: Medicinal cannabis has mixed evidence for treating anxiety and depression, yet patients frequently use it as a treatment. This observational study evaluated the effects of medicinal cannabis initiation in adults with clinically significant anxiety and/or depression over a 6-month period. METHODS: Adults with clinically significant anxiety and/or depression initiating medicinal cannabis use in Maryland, USA completed ecological momentary assessment (EMA) and longitudinal follow-up evaluations. Hospital Anxiety and Depression Scale (HADS) assessments were completed at baseline and 1, 3, and 6 months after medicinal cannabis initiation. EMA measures were completed at baseline and daily for 8 weeks after cannabis initiation with measures collected before each cannabis use and at time of expected peak effect. Changes in anxiety and depression were evaluated using linear mixed effect models. RESULTS: Significant decreases from baseline in anxiety and depression were observed, with mean scores dropping below clinically significant levels within three months of initiation. EMA data indicated that most participants selected THC-dominant cannabis and acute reductions in anxiety, depression, and perceived driving ability along with increased ratings of feeling "high". Acute effects were dose-dependent: 10-15 mg of oral THC and at least 3 puffs of vaporized cannabis yielded the most robust reductions in anxiety and depression. CONCLUSIONS: Initiation of THC-dominant medicinal cannabis was associated with acute reductions in anxiety and depression, and sustained reductions in overall symptom severity over a 6-month period. Controlled clinical trials are needed to further investigate the efficacy and safety of medicinal cannabis for acute anxiety and depression symptom management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA.
- Department of Mental Health, Johns Hopkins University School of Public Health, 1812 Ashland Ave., Baltimore, MD 21205, USA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA; Centre for Alco…
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA. Electronic address: jstric14@jhmi.edu.
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
- Thomas Jefferson University
- National Institutes of Health
Zitieren
APA
Wolinsky, D., Mayhugh, R. E., Surujnarain, R., Thrul, J., Vandrey, R., & Strickland, J. C. (2025). Acute and chronic effects of medicinal cannabis use on anxiety and depression in a prospective cohort of patients new to cannabis. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.119829
Vancouver
Wolinsky D, Mayhugh RE, Surujnarain R, Thrul J, Vandrey R, Strickland JC. Acute and chronic effects of medicinal cannabis use on anxiety and depression in a prospective cohort of patients new to cannabis. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.119829
BibTeX
@article{Wolinsky2025,
author = {Wolinsky, David and Mayhugh, Rhiannon E and Surujnarain, Renuka and Thrul, Johannes and Vandrey, Ryan and Strickland, Justin C},
title = {Acute and chronic effects of medicinal cannabis use on anxiety and depression in a prospective cohort of patients new to cannabis},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2025.119829}
}
EUVIMED